[Mental deterioration in arteriosclerotic subjects before and after treatment with SP 54 and with a placebo].
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D001523:Mental Disorders / Q000517:prevention & control*; D008875:Middle Aged; D010919:Placebos / Q000627:therapeutic use*
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010919:Placebos
Deterioramento mentale in soggetti arteriosclerotici prima e dopo trattamento con SP 54 e con "placebo".